Goldsite Diagnostics Inc.
深圳市国赛生物技术有限公司
Complete regulatory portfolio for Goldsite Diagnostics Inc. in China's medical device market. This registrant has 186 medical devices registered with China NMPA, with registrations dating from Jan 24, 2019 to Jan 21, 2025.
Browse the complete device portfolio including device classifications, registration numbers, approval dates, and technical specifications. Pure Global AI provides free access to comprehensive China NMPA registration data, helping global MedTech companies analyze market presence and regulatory compliance for Chinese medical device manufacturers.
Free Database
Powered by Pure Global AI
NMPA Official Data
186 Devices
Company Overview
Total Devices
186
Province/Region
Guangdong
广东
Address
103C, 503C, 504D Science and Technology Building, Merchants Street, Nanshan District, Shenzhen; No. 3A, No. 4A, Auxiliary Building of Science and Technology Building
深圳市南山区招商街道科技大厦103C、503C、504D；科技大厦辅楼3A号、4A号
Registration Timeline
Earliest Approval
Jan 24, 2019
Latest Approval
Jan 21, 2025
Device Class Distribution
Breakdown of 186 devices by regulatory classification
Class II
179
96.2% of total
Class III
7
3.8% of total
Registered Devices (10 most recent shown)
Click on any device for detailed registration information